(TheDiplomat) CEO Son has identified foreign markets as the key to Softbank’s fu


Failed T-Mobile Bid May Not Deter Softbank From New Acquisitions
CEO Masayoshi Son has identified foreign markets as the key to Softbank’s future.

Sprint Corp., which is majority owned by Japan’s mobile provider Softbank, dropped its bid to acquire T-Mobile U.S. on Wednesday. The news caused shares in all three companies to drop, as Softbank had planned the tie up between America’s third and fourth largest mobile carriers in order to compete with the country’s much larger rivals Verizon Communications Inc. and AT&T Inc. While the failed merger is a setback for Softbank and its acquisition hungry founder Masayoshi Son, there is speculation that news of a new Softbank deal may be forthcoming.

Although there was skepticism that a deal between Sprint and T-Mobile would be able to surmount regulatory and antitrust obstacles, the two were intent on pursuing the deal because of the economies of scale combining their networks would entail. With investment costs for expanding wireless networks quite absorbent, all parties involved saw it as a good way to quickly reach greater parity with the number one and number two carriers in the U.S. Softbank’s purchase of a majority stake in Sprint last year for $21.6 billion made it the world’s largest mobile provider, yet the company still wanted a greater share of the American market.

While Sprint and T-Mobile finally announced that they could not agree on how to equitably share the risk of the deal falling through during the lengthy regulatory approval process, which could have taken a year or two, Softbank in all likelihood will not be deterred by the setback. Son, the company’s CEO, is not expected to wait long before announcing a new investment plan, as he personally championed the acquisition of many of the more than 1,300 companies Softbank owns a stake in.

An analyst at SMBC Nikko, Satoru Kikuchi, says that “Softbank may already have another acquisition target,” and he expects Son to announce another deal this year, or maybe as soon as the end of this month. Son may even indicate his possible strategy while briefing investors during a quarterly earnings meeting this Friday. There is speculation that instead of trying to purchase another mobile provider, Softbank may try to expand its content, for instance its large mobile game presence, or grow into other media. Macquarie Securities analyst Nathan Ramler also expects that “SoftBank/Sprint have other ideas on how to gain the scale and momentum they want in the U.S. market.” Others speculate that Son will look to Europe, where “acquiring an operator in a high-ARPU [average revenue per user] Western European market could be next on the list,” according to Counterpoint analyst Neil Shah.

In fact, there is little to keep Son from looking abroad to expand Softbank’s reach. The Japanese mobile market is already saturated, and the company will find it difficult to take market share from its much bigger domestic rival NTT Docomo. As the Japanese mobile market eventually shrinks along with the population, Softbank in all likelihood will go the way of other Japanese corporate giants (specifically the auto industry), and expand its presence abroad in order to sustain its growth. This strategy has been show to allow Japanese companies to continue to grow and remain profitable. The downside for Japan is that this new international growth does little to contribute to the country’s perennially struggling economy.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance/SSS
: THOR -26.4%, ELON -17%, BWC -12.6%, GEOS -9.5%, RNDY -9.5%, ANAD -9.1%, IO -8.4%, CSOD -8.2%, COUP -7.6%, TXTR -6.6%, OSUR -6%, TNGO -5.4%, ATML -5.2%, ATRS -5.2%, FTK -5.1%, ZEUS -4.9%, PHMD -4.7%, ERII -4.6%, CLDX -4.5%, ZU -4.5%, SD -4.5%, NVAX -4.1%, GPOR -3.9%, IXYS -3.9%, DVAX-3.9%, DRTX -3.7%, WIN -3.5%, CPA -3.3%, EVC -3.2%, NIHD -3.2%, BDBD -3%, CECE -3%, LAMR -3%, RDUS -2.8%, SABR -2.8%, IDCC -2.7%, FRED -2.6%, ACAS -2.4%, GMCR -2.2%, TSE -2.2%, SRPT -2%, MWE -1.9%, DSCI -1.9%, AUXL -1.8%, HIL -1.6%, MYL -1.6%, HRC -1.6%, YY -1.5%, CXW -1.5%, PRSC -1.5%, TOPS -1.5%, AGYS -1.4%, CPE -1.3%, LPI -1.3%, PHX-1.3%, CGI -1.1%, NVTL -1.1%, CTB -1%, MPEL -1%, COST -1%.

Select metals/mining stocks trading lower: TC -2.2%, AU -1.5%, AU -1.5%, HL -1.2%, HL -1.2%, IAG -1.1%, HMY -1%, BHP -0.5%, MT -0.4%.

Other news: NYMX -8% (Paul Averback sold in a private transaction for financial planning purposes 470,600 common shares of NYMX for a total consideration of $2.4 mln), UMPQ -3.5% (announces secondary offering of 15 mln shares held by Thomas H. Lee Partners and Warburg Pincus), SHPG -1.8% (still checking), PT -1.5% (still checking), YY -1.5% (Shanghai -1.3% overnight), EBS-1.3% (submits Biologics license application to FDA for Anthrax Immune Globulin Intravenous), ASTM -0.9% (filed for a $20 mln common stock offering), RSPP -0.8% (announces pricing of 10 mln shares of common stock offering at $25.65/share).

Analyst comments: NUS -0.6% (downgraded to Neutral from Overweight at JP Morgan), AET -0.6% (downgraded to Neutral from Buy at Goldman), UNH -0.6% (removed from Conviction Buy list at Goldman), PERI -0.5% (downgraded to Hold from Buy at Needham), VOD -0.4% (downgraded to Mkt Perform from Outperform at Raymond James).

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance/SSS
: SAAS +18.5%, LGP +18.4%, SSYS +12.4%, JACK +11.2%, HZNP +11%, MCP +10.8%, GDP +9.4%, TRMR +8.7%, MBI +7%, MIDD +6.7%, FOXA +5.2%, HAR +5.1%, TPH +4.8%, SUNE +4.8%, DXCM +4.7%, HIMX +4.6%, PKT +4.5%, LDRH +4.5%, EVHC +4.3%, ATHM +4.3%, CRIS +4.2%, QIWI +4.1%, DEG +3.8%, WTI +3.7%,BREW +3.5%, TROX +3.5%, EVRY +3.5%, TDC +3.4%, WWAV +3.3%, KERX +3.2%, DEPO +3.1%, MUSA +2.9%, CTL +2.9%, VNDA +2.9%, WEN +2.8%, JBT +2.6%, OFIX +2.5%, AFSI +2.5%, EXAR +2.4%, RIG +2.3%, RDN +2.3%, PACD +2.2%, DYN +2.2%, ZFGN +2.2%, AGU +2.1%, CSII +2%, ICE +2%, BKD +1.8%, TWO +1.8%, NLY +1.7%, TCAP +1.7%, AAON +1.6%,CDXS +1.5%, WR +1.5%, DNB +1.3%, TEG +1.3%, PMT +1.3%, RIO +1.3%, MRIN +1.2%, RGLD +1.2%, DUK +1.2%, ITMN +1.1%, ETP +1.1%, SN +1.1%, SYMC +1.1%, MNK +1.1%.

M&A news: CST +6.6% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), NEM +0.8% (exec says company still open to merger with Barrick Gold (ABX), according to reports).

Select solar names showing strength: HSOL +2.9%, JASO +2.4%, TAN +2.4%, TSL +1.8%, CSIQ +1.7%, JKS +1.4%, YGE +1.2%, FSLR +0.7%.

Other news: LIME +203.8% (announced utility program contract win valued at $180 mln), OGXI +23.3% (announces appointment of John Bencich as VP and CFO), LGP +18.4% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), MCP +10.8% (announces commitment for a $400 mln financing arrangement ), MDCO +10.6% (received FDA approval of Orbactiv (oritavancin) for the treatment of skin infections), CTRP +10% (co and Priceline Group (PCLN) expand partnership; Priceline to make $500 mln investment in Ctrip), GTXI +7.8% (filed for a ~22.156 mln share common stock shelf offering which includes ~10.18 mln shares of its common stock issuable upon the exercise of outstanding warrants, which are held by the selling stockholders), VJET +6.2% (following SSYS results), CTIC +6.1% (receives FDA Fast Track Designation for Pacritinib, a novel JAK2 Inhibitor for the treatment of myelofibrosis), XONE +5.9% (following SSYS results), PERY +4.9% (following late move higher on volume -- attributed to M&A speculation), DDD +3.4% (following SSYS results), WBAI +2.1% (enters into strategic partnership with China Mobile Limited (CHL)), DB +2% (peer Commerzbank trading higher after results), VMW +1.7% (announced authorization of stock repurchase program of up to $1 bln of its Class A common stock), BKS +1.5% (Google and Barnes & Noble (BKS) want to compete with Amazon (AMZN) on speedy book delivery, according to reports), MNK +1.1% (announced settlement of OFIRMEV (acetaminophen) injection patent litigation with Fresenius Kabi USA), BAC +0.9% (reports suggesting $16.5 bln DoJ settlement).

Analyst comments: AOL +3.3% (upgraded to Buy from Hold at Cantor Fitzgerald), CCL +2.1% (upgraded to Buy from Neutral at BofA/Merrill), ANR +1.6% (upgraded to Neutral from Sell at UBS), ARMH +1.3% (upgraded to Buy from Hold at The Benchmark Company), WAG +1% (upgraded to Hold from Sell at Cantor Fitzgerald)

>>> US Early premarket gappers

Early premarket gappers

Gapping up: LIME +127.4%, CST +14.8%, SAAS +14.7%, LGP +12.4%, LGP +12.4%, SSYS+11.5%, JACK +11.2%, CTRP +10.9%, MCP +10.8%, MDCO +10.8%, HZNP +9%, TRMR +8.7%,HIMX +8.2%, GTXI +7.8%, ATHM +6.8%, MIDD +6.7%, GDP +6.2%, PERY +4.9%, LPI +4.9%,PKT +4.5%, LDRH +4.5%, EVHC +4.3%, FOXA +4.3%, DXCM +3.8%, WTI +3.7%, BREW +3.5%,EVRY +3.5%, SUNE +3.3%, MBI +3.2%, DEPO +3.1%, MUSA +2.9%, CTL +2.9%, NRF +2.9%,RIG +2.7%, OFIX +2.5%, PACD +2.2%, DYN +2.2%, ZFGN +2.2%, CCL +2.1%, AGU +2.1%, CSII+2%, ICE +2%, CTB +1.9%, ETP +1.8%, BKD +1.8%, NLY +1.8%, TWO +1.8%, VMW +1.7%,TCAP +1.7%, HAR +1.6%, AAON +1.6%, BKS +1.5%, CDXS +1.5%, WR +1.5%, DB +1.3%, DNB+1.3%, TEG +1.3%, PMT +1.3%, MRIN +1.2%, RGLD +1.2%, SRPT +1.2%, MNK +1.1%, ITMN+1.1%, SN +1.1%, SYMC +1.1%, MNK +1.1%, WWAV +1.1%, TIBX +1%

Gapping down: THOR -27.7%, ELON -17%, BWC -12.6%, GEOS -11.5%, RNDY -9.5%, ANAD-9.1%, IO -8.4%, CSOD -8.2%, NYMX -8%, COUP -7.6%, TXTR -6.6%, OSUR -6%, ZU -5.9%,TNGO -5.4%, SD -5.2%, FTK -5.1%, ZEUS -4.9%, MPEL -4.7%, ERII -4.6%, CLDX -4.5%, CRIS-4.2%, ATML -4.1%, NVAX -4.1%, GPOR -3.9%, IXYS -3.9%, PT -3.6%, EVC -3.2%, NIHD -3.2%,HL -3.1%, BDBD -3%, CECE -3%, LAMR -3%, RDUS -2.8%, ACAS -2.4%, TSE -2.2%, EXAR -2%,SHPG -1.9%, AUXL -1.8%, CNVR -1.6%, GMCR -1.6%, HIL -1.6%, HRC -1.6%, UMPQ -1.5%,CXW -1.5%, PRSC -1.5%, YY -1.3%, CPE -1.3%, AU -1.2%, CGI -1.1%, NVTL -1.1%, WIN -1%, JD-0.9%

>>> DRAX -4.65% on news

*DRAX SAYS WILL NOW CONSIDER OPTIONS FOR FULL CONVERSION OF UNIT
*DRAX SAYS WON'T APPEAL AGAINST COURT OF APPEAL DECISION
*DRAX: COURT DISMISSED CO. APPLICATION FOR JUDICIAL REVIEW
*DRAX CONFIRMS COURT OF APPEAL ALLOWS DECC APPEAL

(BFW) M&A Breakup Risk Elevated on Potential Tax Legislation: Citi


M&A Breakup Risk Elevated on Potential Tax Legislation: Citi
2014-08-07 09:22:36.887 GMT


By Sam Chambers
Aug. 7 (Bloomberg) -- The U.S. Treasury will probably firm
up its proposals to curb tax benefits of corporate inversion
deals in the S/T and enact legislation by year end, Citi says
after a call with a legal expert.
* Citi: U.S. may seek to place limits on the uses of offshore
cash and the deductibility of interest expenses incurred to
fund overseas operations
* Cos. may expedite pending deals; regulation would
increase break-up risk of deals involving significant
amounts of offshore cash, such as Covidien/Medtronic
* In pharma, Citi prefers Actavis and Teva, due to their
greater focus on organic growth
* NOTE: Yday Deutsche Bank said the probability of legislative
action on inversions this year is very low
* NOTE: Walgreen/Alliance Boots to be based in the U.S.
* NOTE: Yday AstraZeneca, Shire fell after the Treasury said
it was examining whether it had the authority to bypass
Congress and curb corporate inversions


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Sam Chambers in London at +44-20-7673-2021 or
schambers7@bloomberg.net
To contact the editors responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
Gaurav Panchal

(BFW) *RUSSIA IS READY TO REVIEW USE OF TRANSSIBERIAN AIR ROUTES

--> -ve Euorpean Carriers


BN 08/07 08:32 *RUSSIA IS READY TO REVIEW USE OF TRANSSIBERIAN AIR ROUTES
BN 08/07 08:30 *RUSSIAN FOOD PRODUCERS WILL SUPPLY MARKET: MEDVEDEV
BFW 08/07 08:29 *MEDVEDEV SAYS FOOD IMPORT BAN WAS DIFFICULT DECISION FOR RUSSIA
BFW 08/07 08:29 *MEDVEDEV SAYS RUSSIA FORCED TO IMPOSE RETALIATORY MEASURES
BN 08/07 08:29 *MEDVEDEV SAYS FOOD IMPORT BAN WAS DIFFICULT DECISION FOR RUSSIA
BN 08/07 08:28 *MEDVEDEV SAYS RUSSIA FORCED TO IMPOSE RETALIATORY MEASURES
BFW 08/07 08:27 *RUSSIA BANS FOOD IMPORTS FROM EU, US, CANADA, AUSTRALIA, NORWAY
BN 08/07 08:27 *RUSSIA BANS FOOD IMPORTS FROM EU, US, CANADA, AUSTRALIA, NORWAY
BN 08/07 08:26 *RUSSIA BANS FOODS FROM AUSTRALIA, CANADA, NORWAY AS WELL
BN 08/07 08:25 *RUSSIA BANS ALL DAIRY, CHEEESE, FISH FROM EU, US
BN 08/07 08:25 *RUSSIA BANS ALL BEEF, PORK, FRUIT, VEGETABLE FROM EU, US
BFW 08/07 08:24 *MEDVEDEV SAYS RUSSIA WAITED LONG TIME TO REACT TO SANCTIONS
BN 08/07 08:24 *MEDVEDEV SAYS RUSSIA WAITED LONG TIME TO REACT TO SANCTIONS

*RUSSIA IS READY TO REVIEW USE OF TRANSSIBERIAN AIR ROUTES
2014-08-07 08:32:31.367 GMT

--JENNY PARIS

-0- Aug/07/2014 08:32 GMT